The regulation of new drugs by the Food and Drug Administration : the new drug review process : hearings before a subcommittee of the Committee on Government Operations, House of Representatives, Ninety-seventh Congress, second session, August 3 and 4, 1982.

Review Panel on New Drug Regulation : final report.

United States. Dept. of Health, Education, and Welfare. Review Panel on New Drug Regulation.

January 1977

To be accompanied by 4 vols. of Appendices.Issued May 1977.Cover title.Includes bibliographical refe...

Food safety and quality : FDA needs stronger controls over the approval process for new animal drugs : report to the Chairman, Human Resources and Intergovernmental Relations Subcommittee, Committee on Government Operations, House of Representatives /

United States. General Accounting Office.
United States. Congress. House of Representatives. Committee on Government Operations. Human Resources and Intergovernmental Relaltions Subcommittee.

"B-246269"--P. 1."GAO/RCED-92-63.""January 1992."Cover title.Includes bibliographical references.Mod...

Drug regulation : FDA's computer systems need to be better managed : report to the Chairman, Subcommittee on Intergovernmental Relations and Human Resources, Committee on Government Operations, House of Representatives /

United States. General Accounting Office.

"B-223076"--P. [1]."GAO/IMTEC-86-32.""September 1986."Distributed to depository libraries in microfi...

The Food and Drug Administration's process for approving new drugs [microform] : oversight : hearings before the Subcommittee on Science, Research, and Technology of the Committee on Science and Technology, U.S. House of Representatives, Ninety-sixth Congress, first session, June 19, 21, July 11, 1979.

United States. Congress. House. Committee on Science and Technology. Subcommittee on Science, Research, and Technology.

Reuse of record except for individual research requires license from Congressional Information Servi...

Drug regulation reform--oversight [microform] : hearing before the Subcommittee on Health and the Environment of the Committee on Interstate and Foreign Commerce, House of Representatives, Ninety-sixth Congress, second session ....

United States. Congress. House. Committee on Interstate and Foreign Commerce. Subcommittee on Health and the Environment.

January 1980

Reuse of record except for individual research requires license from Congressional Information Servi...

Drug regulation reform act of 1978 : hearings before the Subcommittee on Health and Scientific Research of the Committee on Human Resources, United States Senate, Ninety-fifth Congress, second session on S. 2755.

United States. Congress. Senate. Committee on Human Resources. Subcommittee on Health and Scientific Research.

January 1978

Hearings held in Washington, Mar. 17-May 17, 1978, and in Rockville, Md., May 18, 1978.Mode of acces...

Regulation of trade in drugs: hearings, Ninety-first Congress, second session, on S. 1575, to regulate trade in drugs and devices by prohibiting the dispensing of drugs or devices by medical practitioners and their participation in profits from the dispensing of such products, except under certain circumstances, and for other purposes, June 16 and 17, 1970.

United States. Congress. Senate. Committee on Commerce. Consumer Subcommittee.

January 1970

"Serial no. 91-81."Frank E. Moss, subcommittee chairman.Mode of access: Internet

The Food and Drug Administration's process for approving new drugs : report /

United States. Congress. House. Committee on Science and Technology. Subcommittee on Science, Research, and Technology.

"November 1980.""Serial HHH."At head of title: Committee print.Includes bibliographical references.M...

Review of the administration's drug interdiction efforts : hearings before a subcommittee of the Committee on Government Operations, House of Representatives, Ninety-eighth Congress, first session, February 25, 26; July 6, 7, and 9, 1983.

United States. Congress. House. Committee on Government Operations. Government Information, Justice, and Agriculture Subcommittee.

January 1983

Item 1016-A, 1016-B (microfiche).Distributed to some depository libraries in microfiche.Mode of acce...

FDA's regulation of Zomax : hearings before a subcommittee of the Committee on Government Operations, House of Representatives, Ninety-eighth Congress, first session, April 26 and 27, 1983.

United States. Congress. House. Committee on Government Operations. Intergovernmental Relations and Human Resources Subcommittee.

January 1983

Item 1016-A, 1016-B (microfiche).Distributed to some depository libraries in microfiche."Intergovern...

Food and Drug Administration oversight : hearings before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives.

United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health and the Environment.

"Serial no. 102-116"--Pt. 2."Serial no. 102-25"--Pt. [1]."One Hundred Second Congress, first session...

Oversight of the drug development program of the National Cancer Institute, 1982 : hearing before the Subcommittee on Investigations and General Oversight of the Committee on Labor and Human Resources, United States Senate, Ninety-seventh Congress, second session on examination of effective alternatives toward correcting deficiencies in the use of experimental drugs on cancer patients, March 5, 1982.

United States. Congress. Senate. Committee on Labor and Human Resources. Subcommittee on Investigations and General Oversight.

January 1982

Item 1043-A, 1043-B (microfiche)Includes bibliographical references.Mode of access: Internet

Drug legislation : hearings before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, Ninety-eighth Congress, first session, on drug labeling and advertising, H.R. 1554, new drug application, H.R. 3605, July 25, 1983 : drug abuse, Quaaludes, H.R. 1055, H.R. 1097, October 3, 1983.

United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health and the Environment.

January 1983

Item 1019-A, 1019-B (microfiche)."Serial no. 98-67."Distributed to some depository libraries in micr...

FDA's regulation of Carcinogenic additives : hearing before a subcommittee of the Committee on Government Operations, House of Representatives, One hundredth Congress, first session, June 24, 1987.

United States. Congress. House. Committee on Government Operations. Human Resources and Intergovernmental Relations Subcommittee.

January 1987

Item 1016-A, 1016-B (microfiche)Shipping list no.: 87-659-P.Distributed to some depository libraries...

Continued review of the administration's drug interdiction efforts : hearings before a subcommittee of the Committee on Government Operations, House of Representatives, Ninety-eighth Congress, second session, March 21, 22, 23; June 14, August 1; and September 6, 1984.

United States. Congress. House. Committee on Government Operations. Government Information, Justice, and Agriculture Subcommittee.

January 1985

Item 1016-A, 1016-B (microfiche).Distributed to some depository libraries in microfiche.Mode of acce...

Review Panel on New Drug Regulation : final report.

United States. Dept. of Health, Education, and Welfare. Review Panel on New Drug Regulation.

January 1977

To be accompanied by 4 vols. of Appendices.Issued May 1977.Cover title.Includes bibliographical refe...

Food safety and quality : FDA needs stronger controls over the approval process for new animal drugs : report to the Chairman, Human Resources and Intergovernmental Relations Subcommittee, Committee on Government Operations, House of Representatives /

United States. General Accounting Office.
United States. Congress. House of Representatives. Committee on Government Operations. Human Resources and Intergovernmental Relaltions Subcommittee.

"B-246269"--P. 1."GAO/RCED-92-63.""January 1992."Cover title.Includes bibliographical references.Mod...

Drug regulation : FDA's computer systems need to be better managed : report to the Chairman, Subcommittee on Intergovernmental Relations and Human Resources, Committee on Government Operations, House of Representatives /

United States. General Accounting Office.

"B-223076"--P. [1]."GAO/IMTEC-86-32.""September 1986."Distributed to depository libraries in microfi...

The Food and Drug Administration's process for approving new drugs [microform] : oversight : hearings before the Subcommittee on Science, Research, and Technology of the Committee on Science and Technology, U.S. House of Representatives, Ninety-sixth Congress, first session, June 19, 21, July 11, 1979.

United States. Congress. House. Committee on Science and Technology. Subcommittee on Science, Research, and Technology.

Reuse of record except for individual research requires license from Congressional Information Servi...

Drug regulation reform--oversight [microform] : hearing before the Subcommittee on Health and the Environment of the Committee on Interstate and Foreign Commerce, House of Representatives, Ninety-sixth Congress, second session ....

United States. Congress. House. Committee on Interstate and Foreign Commerce. Subcommittee on Health and the Environment.

January 1980

Reuse of record except for individual research requires license from Congressional Information Servi...

Drug regulation reform act of 1978 : hearings before the Subcommittee on Health and Scientific Research of the Committee on Human Resources, United States Senate, Ninety-fifth Congress, second session on S. 2755.

United States. Congress. Senate. Committee on Human Resources. Subcommittee on Health and Scientific Research.

January 1978

Hearings held in Washington, Mar. 17-May 17, 1978, and in Rockville, Md., May 18, 1978.Mode of acces...

Regulation of trade in drugs: hearings, Ninety-first Congress, second session, on S. 1575, to regulate trade in drugs and devices by prohibiting the dispensing of drugs or devices by medical practitioners and their participation in profits from the dispensing of such products, except under certain circumstances, and for other purposes, June 16 and 17, 1970.

United States. Congress. Senate. Committee on Commerce. Consumer Subcommittee.

January 1970

"Serial no. 91-81."Frank E. Moss, subcommittee chairman.Mode of access: Internet

The Food and Drug Administration's process for approving new drugs : report /

United States. Congress. House. Committee on Science and Technology. Subcommittee on Science, Research, and Technology.

"November 1980.""Serial HHH."At head of title: Committee print.Includes bibliographical references.M...

Review of the administration's drug interdiction efforts : hearings before a subcommittee of the Committee on Government Operations, House of Representatives, Ninety-eighth Congress, first session, February 25, 26; July 6, 7, and 9, 1983.

United States. Congress. House. Committee on Government Operations. Government Information, Justice, and Agriculture Subcommittee.

January 1983

Item 1016-A, 1016-B (microfiche).Distributed to some depository libraries in microfiche.Mode of acce...

FDA's regulation of Zomax : hearings before a subcommittee of the Committee on Government Operations, House of Representatives, Ninety-eighth Congress, first session, April 26 and 27, 1983.

United States. Congress. House. Committee on Government Operations. Intergovernmental Relations and Human Resources Subcommittee.

January 1983

Item 1016-A, 1016-B (microfiche).Distributed to some depository libraries in microfiche."Intergovern...

Food and Drug Administration oversight : hearings before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives.

United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health and the Environment.

"Serial no. 102-116"--Pt. 2."Serial no. 102-25"--Pt. [1]."One Hundred Second Congress, first session...

Oversight of the drug development program of the National Cancer Institute, 1982 : hearing before the Subcommittee on Investigations and General Oversight of the Committee on Labor and Human Resources, United States Senate, Ninety-seventh Congress, second session on examination of effective alternatives toward correcting deficiencies in the use of experimental drugs on cancer patients, March 5, 1982.

United States. Congress. Senate. Committee on Labor and Human Resources. Subcommittee on Investigations and General Oversight.

January 1982

Item 1043-A, 1043-B (microfiche)Includes bibliographical references.Mode of access: Internet

Drug legislation : hearings before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, Ninety-eighth Congress, first session, on drug labeling and advertising, H.R. 1554, new drug application, H.R. 3605, July 25, 1983 : drug abuse, Quaaludes, H.R. 1055, H.R. 1097, October 3, 1983.

United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health and the Environment.

January 1983

Item 1019-A, 1019-B (microfiche)."Serial no. 98-67."Distributed to some depository libraries in micr...

FDA's regulation of Carcinogenic additives : hearing before a subcommittee of the Committee on Government Operations, House of Representatives, One hundredth Congress, first session, June 24, 1987.

United States. Congress. House. Committee on Government Operations. Human Resources and Intergovernmental Relations Subcommittee.

January 1987

Item 1016-A, 1016-B (microfiche)Shipping list no.: 87-659-P.Distributed to some depository libraries...

Continued review of the administration's drug interdiction efforts : hearings before a subcommittee of the Committee on Government Operations, House of Representatives, Ninety-eighth Congress, second session, March 21, 22, 23; June 14, August 1; and September 6, 1984.

United States. Congress. House. Committee on Government Operations. Government Information, Justice, and Agriculture Subcommittee.

January 1985

Item 1016-A, 1016-B (microfiche).Distributed to some depository libraries in microfiche.Mode of acce...

Review Panel on New Drug Regulation : final report.

United States. Dept. of Health, Education, and Welfare. Review Panel on New Drug Regulation.

January 1977

To be accompanied by 4 vols. of Appendices.Issued May 1977.Cover title.Includes bibliographical refe...

Food safety and quality : FDA needs stronger controls over the approval process for new animal drugs : report to the Chairman, Human Resources and Intergovernmental Relations Subcommittee, Committee on Government Operations, House of Representatives /

United States. General Accounting Office.
United States. Congress. House of Representatives. Committee on Government Operations. Human Resources and Intergovernmental Relaltions Subcommittee.

"B-246269"--P. 1."GAO/RCED-92-63.""January 1992."Cover title.Includes bibliographical references.Mod...

Drug regulation : FDA's computer systems need to be better managed : report to the Chairman, Subcommittee on Intergovernmental Relations and Human Resources, Committee on Government Operations, House of Representatives /

United States. General Accounting Office.

"B-223076"--P. [1]."GAO/IMTEC-86-32.""September 1986."Distributed to depository libraries in microfi...

The regulation of new drugs by the Food and Drug Administration : the new drug review process : hearings before a subcommittee of the Committee on Government Operations, House of Representatives, Ninety-seventh Congress, second session, August 3 and 4, 1982.

Abstract

Extracted data

The regulation of new drugs by the Food and Drug Administration : the new drug review process : hearings before a subcommittee of the Committee on Government Operations, House of Representatives, Ninety-seventh Congress, second session, August 3 and 4, 1982.

Abstract

Extracted data

Related items

Related items